Your browser doesn't support javascript.
loading
Antitrust, Market Exclusivity, and Transparency in the Pharmaceutical Industry.
Sinha, Michael S; Curfman, Gregory D; Carrier, Michael A.
Afiliação
  • Sinha MS; Program On Regulation Therapeutics, And Law, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
  • Curfman GD; Program On Regulation Therapeutics, And Law, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
  • Carrier MA; Center for Health Policy and Law, Northeastern University School of Law, Boston, Massachusetts.
JAMA ; 319(22): 2271-2272, 2018 06 12.
Article em En | MEDLINE | ID: mdl-29801104
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leis Antitruste / Medicamentos Genéricos / Custos de Medicamentos / Indústria Farmacêutica / Competição Econômica Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leis Antitruste / Medicamentos Genéricos / Custos de Medicamentos / Indústria Farmacêutica / Competição Econômica Idioma: En Ano de publicação: 2018 Tipo de documento: Article